Diabetology Xagena
Canagliflozin has reduced the risk of heart failure among patients with type 2 diabetes in the CANVAS Program. The mechanism of protection is uncertain. A study has explored potential mediators of ...
Since December 2019, a pneumonia caused by SARS-CoV-2 which was later named as COVID-19 emerged and many people lost their lives in Wuhan, China. Diabetes is a common comorbidity in patients with C ...
The aim of study was to investigate the efficacy, safety, and tolerability of oral Semaglutide ( Rybelsus ) added to Insulin with or without Metformin. Patients with type 2 diabetes uncontrolled on ...
The purpose of the study was to explore potential mediators of the effects of Canagliflozin ( Invokana ) on heart failure in the CANVAS Program ( CANagliflozin cardioVascular Assessment Study and CANa ...
Diabetes confers a greater excess risk of heart failure in women than men, according to new research in Diabetologia, the journal of the European Association for the Study of Diabetes. Type 1 diabet ...
A new study has found that three quarters of individuals with type 2 diabetes ( T2D ) who were treated with obesity surgery known as Roux-en-Y gastric bypass surgery ( RYGB ) experienced diabetes remi ...
A daily vitamin D supplement does not prevent type 2 diabetes in adults at high risk, according to results from a study funded by National Institute of Diabetes and Digestive and Kidney Diseases ( NID ...
A treatment affecting the immune system effectively has slown the progression to clinical type 1 diabetes in high risk individuals, according to findings from National Institutes of Health-funded rese ...
People with undetected glucose disorders run a higher risk of both myocardial infarction and periodontitis, according to a study published in the journal Diabetes Care by researchers at Karolinska Ins ...
Results of a new subgroup analysis from the phase 3 CREDENCE study, showing Canagliflozin ( Invokana ) has significantly reduced the risk of major cardiovascular ( CV ) events and kidney failure in pa ...
A study has assessed the efficacy and safety of iGlarLixi ( a titratable, fixed-ratio combination of Insulin glargine [ iGlar ] plus Lixisenatide ) in older patients with type 2 diabetes. The post ...
A study has investigated the association of diabetic retinopathy and neuropathy with increased risk of recurrent cardiovascular events in 6068 patients with type 2 diabetes mellitus ( T2DM ) and recen ...
Diabetic individuals commonly report disordered bowel habits. The aim of a study was to report the prevalence and associated factors of chronic diarrhea and chronic constipation in diabetics using a n ...
Prior studies found patients treated with sodium-glucose co-transporter-2 inhibitors ( SGLT-2i ) had lower rates of death and heart failure. Whether the benefits of SGLT-2 inhibitors vary based upon ...
A new Expert Consensus Decision Pathway issued by the American College of Cardiology ( ACC ) has recommended Empagliflozin ( Jardiance ) as the preferred SGLT2 inhibitor for its proven benefit in redu ...
